http://www.acc.org/Feed?clinicalTopicID=3bf13d0e-30db-413f-b1ef-03f397769a1a Clinical Topic Feed: Valvular Heart Disease en /Latest-in-Cardiology/Articles/2026/04/13/18/35/Transcatheter-Aortic-Valve-Implantation Transcatheter aortic valve implantation (TAVI) has become a cornerstone therapy for patients with severe aortic stenosis across a wide spectrum of clinical presentations and surgical risk. Initially reserved for patients at prohibitive or high surgical risk, TAVI is now widely adopted in populations at intermediate and low risk... 1776119820000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/08/13/19/eagles-eye-view-08apr2026 In this week’s View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30. 1775654580000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Pulse-of-ACC Quick-read articles of particular interest to ACC members. 1775045340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Mission-in-Action-Medtronic-Clinician-Update New long-term data from the Evolut Low Risk trial published in JACC underscore how emerging science and evidence continue to shape patient-centered care in structural heart disease – an approach central to the ACC's Vision of using science, knowledge and innovation to optimize patient care and outcomes. 1775045220000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1775037480000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-830am-digrhd-acc-2026 Digoxin lowered the risk of death or new-onset or worsening heart failure (HF) compared with placebo in patients with rheumatic heart disease (RHD), according to results from the Dig-RHD trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774877520000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-protavi-acc-2026 Older patients with coronary artery disease (CAD) for whom PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study presented in a Late-Breaking Clinical Trial session... 1774818600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-trifr-acc-2026 Transcatheter tricuspid edge-to-edge repair (T-TEER) in addition to standard-of-care medical therapy reduced the risk of death, myocardial infarction (MI), stroke and hospitalization for heart failure (HF) compared with standard-of-care alone in patients with severe symptomatic tricuspid regurgitation (TR)... 1774818180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-protecth2h-acc-2026 In the first head-to-head comparison of two embolic protection devices used during TAVR, the investigational Emboliner protection catheter performed comparably to the U.S. Food and Drug Administration (FDA)-approved Sentinel cerebral protection system relative to the composite primary endpoint and secondary endpoint of stroke, according to results from the PROTECT H2H trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-145pm-alert-acc-2026 Electronic clinician notification alerts were shown to be effective in improving the timely evaluation and treatment of patients with severe aortic stenosis (AS) or mitral regurgitation (MR), according to the ALERT trial presented during a Featured Clinical Research session... 1774810200000 Articles and Stories